Literature DB >> 3758360

Prognostic factors in stomach cancer surgery.

P Hermanek.   

Abstract

The most important tumour-related prognostic factors in gastric carcinoma are the depth of infiltration and lymphatic spread. The tumour site itself did not significantly influence prognosis. Histological type according to the WHO classification as well as the histological degree of malignancy were of no significance. Lauréns classification offers no great prognostic difference for tumours within the same stage, but at the time of diagnosis, diffuse type generally shows a more advanced stage than intestinal type. Prognosis is decisively influenced by the choice of surgical therapy, especially by whether the tumour can be curatively removed or not, and by the margins of clearance obtained in curative surgery. The extent of these margins of clearance should be chosen bearing in mind the differences between growth behaviour of intestinal and diffuse type carcinomas. In this fashion, a histology-oriented surgical approach can be achieved.

Entities:  

Mesh:

Year:  1986        PMID: 3758360

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  Morphological predictors of survival in early and advanced gastric carcinoma.

Authors:  P Schmitz-Moormann; P Hermanek; G W Himmelmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Gene expression signature-based prognostic risk score in gastric cancer.

Authors:  Jae Yong Cho; Jae Yun Lim; Jae Ho Cheong; Yun-Yong Park; Se-Lyun Yoon; Soo Mi Kim; Sang-Bae Kim; Hoguen Kim; Soon Won Hong; Young Nyun Park; Sung Hoon Noh; Eun Sung Park; In-Sun Chu; Waun Ki Hong; Jaffer A Ajani; Ju-Seog Lee
Journal:  Clin Cancer Res       Date:  2011-03-29       Impact factor: 12.531

3.  Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients.

Authors:  J P Kim; Y W Kim; H K Yang; D Y Noh
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

4.  Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.

Authors:  M M Heiss; H Allgayer; K U Gruetzner; R Babic; K W Jauch; F W Schildberg
Journal:  Ann Surg       Date:  1997-12       Impact factor: 12.969

5.  Analysis of 154 actual five-year survivors of gastric cancer.

Authors:  S N Hochwald; S Kim; D S Klimstra; M F Brennan; M S Karpeh
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

Review 6.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

7.  Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients.

Authors:  J J Bonenkamp; C J van de Velde; G H Kampschöer; J Hermans; P Hermanek; M Bemelmans; D J Gouma; M Sasako; K Maruyama
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

8.  The influence of age on the growth and spread of gastric carcinoma.

Authors:  C W Janssen; R T Lie; H Maartmann-Moe; R Matre
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

9.  Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.

Authors:  L P Setälä; V M Kosma; S Marin; P K Lipponen; M J Eskelinen; K J Syrjänen; E M Alhava
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

10.  Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.

Authors:  Sang Cheul Oh; Bo Hwa Sohn; Jae-Ho Cheong; Sang-Bae Kim; Jae Eun Lee; Ki Cheong Park; Sang Ho Lee; Jong-Lyul Park; Yun-Yong Park; Hyun-Sung Lee; Hee-Jin Jang; Eun Sung Park; Sang-Cheol Kim; Jeonghoon Heo; In-Sun Chu; You-Jin Jang; Young-Jae Mok; WonKyung Jung; Baek-Hui Kim; Aeree Kim; Jae Yong Cho; Jae Yun Lim; Yuki Hayashi; Shumei Song; Elena Elimova; Jeannelyn S Estralla; Jeffrey H Lee; Manoop S Bhutani; Yiling Lu; Wenbin Liu; Jeeyun Lee; Won Ki Kang; Sung Kim; Sung Hoon Noh; Gordon B Mills; Seon-Young Kim; Jaffer A Ajani; Ju-Seog Lee
Journal:  Nat Commun       Date:  2018-05-03       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.